Clinical Breast Cancer

1

Development of Breast Cancer in a 21-Year-Old Childhood Wilms' Tumor Survivor With a BRCA1 2634delC Mutation

Alexandra M. Dulude, Joyce D'Souza, Nedra Harrison, Ramesh K. Ramanathan

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 119 KB

english, 2011

2

Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab

Nuttapong Ngamphaiboon, Jennifer L. Frustino, Ellen B. Kossoff, Maureen A. Sullivan, Tracey L. O'Connor

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 282 KB

english, 2011

3

Fulvestrant Revisited: Efficacy and Safety of the 500-mg Dose

Anthony Howell, Francisco Sapunar

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 306 KB

english, 2011

4

Nipple Discharge After Nipple-Sparing Mastectomy: Should the Areola Complex Always Be Removed?

Lorenzo Orzalesi, Silvia Aldrovandi, Claudio Calabrese, Donato Casella, Beniamino Brancato, Luigi Cataliotti

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 1.03 MB

english, 2011

5

Early and More Advanced Unifocal and Multifocal Breast Carcinomas and Their Molecular Phenotypes

Tibor Tot

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 819 KB

english, 2011

6

Fulvestrant High Dose vs. Loading Dose vs. Approved Dose: Have We Found the Optimum Dose?

Angela Mae Obermiller, Mehmet Sitki Copur

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 94 KB

english, 2011

7

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert Whorf, Mark Keaton, Padma Nadella, Elisa Krill-Jackson, Joan Kroener, Edward Middleman, Michael Frontiera, Devchand Paul, Timothy Panella, Jane Bromu

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 441 KB

english, 2011

8

Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

Maryam B. Lustberg, Stephen P. Povoski, Weiqiang Zhao, Rebecca M. Ziegler, Yasuro Sugimoto, Amy S. Ruppert, Amy M. Lehman, Donna R. Shiels, Ewa Mrozek, Bhuvaneswari Ramaswamy, Rachel M. Layman, Robert

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 509 KB

english, 2011

9

Partial Breast Irradiation Delivered With Proton Beam: Results of a Phase II Trial

David A. Bush, Jerry D. Slater, Carlos Garberoglio, Sharon Do, Sharon Lum, James M. Slater

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 523 KB

english, 2011

10

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Priya Rastogi, Marc E. Buyse, Sandra M. Swain, Samuel A. Jacobs, André Robidoux, Marcia K. Liepman, Eduardo R. Pajon, Philip A. Dy, Juan G. Posada Jr, Marianne K. Melnik, Fanny Piette, Charles E. Geye

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 570 KB

english, 2011

11

Conservation of the Axilla: An Audit of Sentinel Lymph Node Biopsy After a New Start

Alexandros Apostolopoulos, Abdul Basit, Robert Mark Kirby, James K. Adjogatse, Gary Lambert, Kwok Yin Chan, Angela Hancock, Lisa Hackney, Michael Wall

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 290 KB

english, 2011

12

Management of Early Invasive Breast Cancer in Very Young Women (

Steffi Hartmann, Toralf Reimer, Bernd Gerber

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 390 KB

english, 2011

13

Feasibility and Safety of Weekly Sequential Epirubicin-Paclitaxel as Adjuvant Treatment for Operable Breast Cancer Patients Older than 70 Years

Sylvain Ladoire, Laurie Rambach, Valérie Quipourt, Laure Favier, François Ghiringhelli, Laurent Arnould, Pierre Pfitzenmeyer, Pierre Fumoleau, Bruno Coudert

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 305 KB

english, 2011

14

Aromatase Inhibitor Versus Tamoxifen in Postmenopausal Woman With Advanced Breast Cancer: A Literature-Based Meta-Analysis

Hong-Bin Xu, Yu-Jin Liu, Ling Li

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 352 KB

english, 2011

15

Erratum

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 104 KB

english, 2011

16

Editorial Board/Masthead

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 68 KB

english, 2011

17

Volume 11; Issue 4

Development of Breast Cancer in a 21-Year-Old Childhood Wilms' Tumor Survivor With a BRCA1 2634delC Mutation

Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab

Fulvestrant Revisited: Efficacy and Safety of the 500-mg Dose

Nipple Discharge After Nipple-Sparing Mastectomy: Should the Areola Complex Always Be Removed?

Early and More Advanced Unifocal and Multifocal Breast Carcinomas and Their Molecular Phenotypes

Fulvestrant High Dose vs. Loading Dose vs. Approved Dose: Have We Found the Optimum Dose?

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

Partial Breast Irradiation Delivered With Proton Beam: Results of a Phase II Trial

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Conservation of the Axilla: An Audit of Sentinel Lymph Node Biopsy After a New Start

Management of Early Invasive Breast Cancer in Very Young Women (

Feasibility and Safety of Weekly Sequential Epirubicin-Paclitaxel as Adjuvant Treatment for Operable Breast Cancer Patients Older than 70 Years

Aromatase Inhibitor Versus Tamoxifen in Postmenopausal Woman With Advanced Breast Cancer: A Literature-Based Meta-Analysis

Erratum

Editorial Board/Masthead

Table of Contents